GYRE THERAPEUTICS, INC. - COM (GYRE) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / COM
Symbol
GYRE on Nasdaq
Price per share
$7.06
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
3,095,667
Total reported value
$23,092,842
% of total 13F portfolios
0%
Share change
-314,944
Value change
-$2,342,158
Number of holders
46
Price from insider filings
$7.06
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 46 institutional investors reported holding 3,095,667 shares of GYRE THERAPEUTICS, INC. - COM (GYRE).

Institutional Holders of GYRE THERAPEUTICS, INC. - COM (GYRE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 102 $720 $7.06 1
2025 Q3 3,095,667 $23,092,842 -$2,342,158 $7.46 46
2025 Q2 3,409,744 $25,061,360 +$5,853,520 $7.35 46
2025 Q1 2,609,308 $20,143,986 +$6,336,492 $7.72 43
2024 Q4 1,787,221 $21,627,571 +$923,657 $12.10 38
2024 Q3 1,610,238 $20,192,564 +$4,240,829 $12.54 34
2024 Q2 1,257,751 $15,005,952 +$4,350,610 $11.93 29
2024 Q1 816,435 $14,271,940 +$3,343,587 $17.48 19
2023 Q4 606,775 $15,589,189 +$15,582,189 $25.69 15